3.28
-0.14 (-4.09%)
| Previous Close | 3.42 |
| Open | 3.42 |
| Volume | 170,491 |
| Avg. Volume (3M) | 248,816 |
| Market Cap | 169,582,880 |
| Price / Sales | 2.21 |
| Price / Book | 2.28 |
| 52 Weeks Range | |
| Earnings Date | 30 Jul 2025 - 4 Aug 2025 |
| Profit Margin | -63.24% |
| Operating Margin (TTM) | -79.16% |
| Diluted EPS (TTM) | -0.980 |
| Quarterly Revenue Growth (YOY) | -9.10% |
| Total Debt/Equity (MRQ) | 52.12% |
| Current Ratio (MRQ) | 10.47 |
| Operating Cash Flow (TTM) | -24.17 M |
| Levered Free Cash Flow (TTM) | -8.84 M |
| Return on Assets (TTM) | -21.77% |
| Return on Equity (TTM) | -52.88% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Bearish | Mixed |
| Medical Devices (Global) | Bearish | Mixed | |
| Stock | Sight Sciences, Inc. | Bearish | Bearish |
AIStockmoo Score
| Analyst Consensus | -3.5 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | -1.0 |
| Technical Oscillators | 2.0 |
| Average | -1.13 |
|
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Value |
| % Held by Insiders | 19.93% |
| % Held by Institutions | 50.02% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Kck Ltd. | 31 Dec 2024 | 4,374,975 |
| B Group, Inc. | 31 Dec 2024 | 629,370 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 4.00 (Stifel, 21.95%) | Buy |
| Median | 3.25 (-0.92%) | |
| Low | 3.00 (Lake Street, -8.54%) | Hold |
| 3.00 (Citigroup, -8.54%) | Hold | |
| Average | 3.38 (3.05%) | |
| Total | 1 Buy, 3 Hold | |
| Avg. Price @ Call | 2.63 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Lake Street | 09 May 2025 | 3.00 (-8.54%) | Hold | 3.08 |
| 06 Mar 2025 | 2.50 (-23.78%) | Hold | 2.49 | |
| Piper Sandler | 06 Mar 2025 | 3.50 (6.71%) | Hold | 2.49 |
| Stifel | 06 Mar 2025 | 4.00 (21.95%) | Buy | 2.49 |
| Citigroup | 04 Mar 2025 | 3.00 (-8.54%) | Hold | 2.47 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |